PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.90
Bid: 1.80
Ask: 2.00
Change: 0.30 (15.79%)
Spread: 0.20 (11.111%)
Open: 1.90
High: 2.20
Low: 2.20
Prev. Close: 1.90
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

Wed, 28th Jun 2023 20:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Wednesday and not separately reported by Alliance News:

----------

All Things Considered Group PLC - London-based music firm providing talent management, live booking and livestreaming - Intends to raise GBP4 million through a placing and subscription for shares at 92.5 pence each. Proceeds will be used primarily to buy a 60% holding in Sandbag Ltd, a full-service merchandise company for GBP2.4 million, and provide capital for future accretive opportunities. Expects deal to be earnings accretive and mark a substantial addition to the group's client base.

----------

T42 IOT Tracking Solutions PLC - Jersey-based real-time tracking, security, and monitoring solutions provider - Reports revenue in year to December 31, 2022 of USD4.0 million, down 2.4% from USD4.1 million, the year prior. Pretax loss narrows to USD1.0 million from USD3.0 million. Sees a continuation of post-Covid and supply chain issues that have impacted performance, despite several successful trials of its technology by potential customers. Also experiences delays in the anticipated substantial orders from its Latin America distributor. Targeting a significant improvement in revenue and gross margins in the rest of 2023.

----------

Xpediator PLC - Braintree, England-based freight management services provider - Expects court sanction hearing to approve the scheme facilitating the takeover by funds advised by BaltCap, Cogels Investments Ltd and Nuoma IR Kapitalas to take place next week Thursday. Shares in Xpediator expected to be cancelled on July 10.

----------

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says all resolutions except special resolutions 12 and 13, concerning disapplication of statutory pre-emption rights for allowing issue of shares for cash and share options, were passed.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
13 Jul 2022 14:44

IN BRIEF: ValiRx shares jump on breast cancer drug candidate progress

ValiRx PLC - Nuneaton, England-based drug development company - Completes the evaluation of the impact of a peptide drug candidate against triple negative breast cancer. Evaluation concludes there is "good evidence" of biological activity and a "strong" rationale for further development. Adds that the drug candidate was investigated over nine months. Tests also demonstrate promising data on ovarian cancer cells, in addition to the targeted breast cancer cells. As a result, ValiRx has notified the academic team and intellectual property & licensing team at King's College London that it wants to proceed to full in-licensing.

Read more
5 Jul 2022 15:51

IN BRIEF:ValiRx gains GBP1.0 million from Turner Pope broker option

ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises GBP1.0 million before expenses.

Read more
30 Jun 2022 17:31

TRADING UPDATES: M&C Saatchi expects to deliver on annual profit

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jun 2022 11:35

AIM WINNERS & LOSERS: Frasers invests in MySale; Kefi keeps license

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
23 Jun 2022 16:02

UK shareholder meetings calendar - next 7 days

Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
Tuesday 28 June 
4D Pharma PLCAGM
Acceler8 Ventures PLCAGM
Airtel Africa PLCAGM
Alina Holdings PLCAGM
Aquila Energy Efficiency Trust PLCAGM
Attraqt Group PLCAGM
Bay Capital PLCAGM
Capital & Counties Properties PLCAGM
CMO Group PLCAGM
Corre Energy BVAGM
Creo Medical Group PLCAGM
Futura Medical PLCAGM
Gama Aviation PLCAGM
ICG Enterprise Trust PLCAGM
ImmuPharma PLCAGM
IQE PLCAGM
Katoro Gold PLCAGM
Rockhopper Exploration PLCAGM
Sound Energy PLCAGM
TP Group PLCAGM
UK Oil & Gas PLCAGM
Volvere PLCAGM
Zegona Communications PLCAGM
Wednesday 29 June 
Africa Opportunity Fund LtdAGM
Argo Blockchain PLCAGM
Atome Energy PLCAGM
Brave Bison Group PLCAGM
Concurrent Technologies PLCAGM
Eden Research PLCAGM
Facilities by ADF PLCAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Hurricane Energy PLCAGM
i(x) Net Zero PLCAGM
Lords Group Trading PLCAGM
MaxCyte IncAGM
Meggitt PLCAGM
Mobile Tornado Group PLCAGM
NB Distressed Debt Investment Fund LtdAGM
NetScientific PLCAGM
Provident Financial PLCAGM
RA International Group PLCAGM
Reabold Resources PLCAGM
Symphony Environmental Technologies PLCAGM
Team17 Group PLCAGM
ThinkSmart LtdGM re approval for capital return
Trinity Exploration & Production PLCAGM
URA Holdings PLCAGM
XP Factory PLCAGM
Zaim Credit Systems PLCAGM
Thursday 30 June 
3i Group PLCAGM
Ashtead Technology Holdings PLCAGM
Borders & Southern Petroleum PLCAGM
Caspian Sunrise PLCAGM
Cobra Resources PLCAGM
Crimson Tide PLCAGM
ECSC Group PLCAGM
Evraz PLCAGM
Gresham House Energy Storage Fund PLCAGM
GRIT Investment Trust PLCAGM
Gulf Marine Services PLCAGM
Hamak Gold LtdAGM
Hemogenyx Pharmaceuticals PLCAGM
Immotion Group PLCAGM
Inspiration Healthcare Group PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kropz PLCAGM
Likewise Group PLCAGM
Live Co Group PLCAGM
Location Sciences Group PLCAGM
LoopUp Group PLCAGM
M&C Saatchi PLCAGM
Microsaic Systems PLCAGM
Nostra Terra Oil & Gas CoAGM
Pathfinder Minerals PLCAGM
Playtech PLCAGM
Primorus Investments PLCAGM
Rockfire Resources PLCAGM
Roquefort Therapeutics PLCAGM
Sanne Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serica Energy PLCAGM
Supply@ME Capital PLCAGM
Surface Transforms PLCAGM
Synairgen PLCAGM
Tower Resources PLCAGM
Trainline PLCAGM
ValiRx PLCAGM
Victoria Oil & Gas PLCAGM
Watchstone Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
17 Jun 2022 13:55

ValiRx expecting to grant extension of exclusivity to TheoremRx

(Sharecast News) - Cancer therapeutics and women's health-focussed ValiRx updated the market on its proposed sub-licensing agreement with TheoremRx for 'VAL201' on Friday.

Read more
17 Jun 2022 10:46

AIM WINNERS & LOSERS: M&C Saatchi pulls Next Fifteen deal support

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
17 Jun 2022 10:41

ValiRx shares drop as cancer drug sub-licensing progress stalls

(Alliance News) - ValiRx PLC on Friday said it is expecting to be asked to extend the exclusivity period between itself and TheroemRx Inc regarding the proposed sub-licence of cancer treatment VAL201.

Read more
7 Jun 2022 19:03

IN BRIEF: ValiRx widens annual loss as R&D costs climb

ValiRx PLC - Nuneaton, England-based drug development company - Widens pretax loss in 2021 to GBP1.7 million from GBP1.5 million the previous year. Research and development costs rise 32% to GBP303,789 in the year from GBP230,115 a year prior. Total assets at December 31 fall to GBP3.5 million from GBP4.9 million at the end of 2020. Chief Executive Suzanne Dilly says the work completed during 2021 has provided a "strong foundation" for the company moving forward.

Read more
23 Mar 2022 20:53

TRADING UPDATES: Arecor Therapeutics wins patent approval in US

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
15 Mar 2022 17:18

TRADING UPDATES: Amigo heads to vote; UniVision court date pushed back

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Mar 2022 10:53

AIM WINNERS & LOSERS: Eco Animal expects earnings below consensus

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
14 Feb 2022 22:19

TRADING UPDATES: BioPharma backs Collegium; Eurasia creates Kola

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Monday and not separately reported by Alliance News:

Read more
5 Jan 2022 10:50

AIM WINNERS & LOSERS: AdvancedAdvT buys into M&C Saatchi

AIM WINNERS & LOSERS: AdvancedAdvT buys into M&C Saatchi

Read more
5 Jan 2022 09:21

ValiRx enters agreement and potential sub-license with TheoremRx

ValiRx enters agreement and potential sub-license with TheoremRx

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.